Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.79 CAD | -.--% | -7.06% | +71.74% |
May. 29 | IM Cannabis Corp. announced that it has received CAD 2.091977 million in funding | CI |
May. 26 | IM Cannabis Corp. announced that it expects to receive CAD 2.091977 million in funding | CI |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 49.55 | 399 | 287.7 | 9.84 | 6.161 | 10.58 | - |
Enterprise Value (EV) 1 | 49.55 | 399 | 287.7 | 9.84 | 6.161 | 10.58 | 10.58 |
P/E ratio | - | - | - | - | - | - | - |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | 5.46 x | 25.1 x | 5.3 x | 0.18 x | 0.13 x | 0.2 x | 0.17 x |
EV / Revenue | 5.46 x | 25.1 x | 5.3 x | 0.18 x | 0.13 x | 0.2 x | 0.17 x |
EV / EBITDA | -27.3 x | -71.3 x | -13.1 x | -0.86 x | -0.77 x | -2.43 x | -131 x |
EV / FCF | - | - | -7,387,347 x | -692,887 x | - | - | - |
FCF Yield | - | - | -0% | -0% | - | - | - |
Price to Book | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 3,644 | 3,974 | 6,818 | 7,570 | 13,394 | 13,394 | - |
Reference price 2 | 13.60 | 100.4 | 42.20 | 1.300 | 0.4600 | 0.7900 | 0.7900 |
Announcement Date | 4/20/20 | 4/23/21 | 3/31/22 | 3/29/23 | 3/28/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net sales 1 | 9.074 | 15.89 | 54.3 | 54.34 | 48.8 | 53.35 | 63.58 |
EBITDA 1 | -1.814 | -5.592 | -22.03 | -11.49 | -7.97 | -4.348 | -0.0808 |
EBIT 1 | - | - | -38.39 | -30.79 | -12.79 | -11.9 | -5.355 |
Operating Margin | - | - | -70.7% | -56.67% | -26.21% | -22.31% | -8.42% |
Earnings before Tax (EBT) 1 | - | - | -18.01 | -26.06 | -9.457 | -13.93 | -7.329 |
Net income 1 | - | - | -18.52 | -188.9 | -9.498 | -13.7 | -6.002 |
Net margin | - | - | -34.1% | -347.64% | -19.46% | -25.67% | -9.44% |
EPS | - | - | - | - | - | - | - |
Free Cash Flow | - | - | -38.95 | -14.2 | - | - | - |
FCF margin | - | - | -71.73% | -26.14% | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 4/20/20 | 4/23/21 | 3/31/22 | 3/29/23 | 3/28/24 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 20.03 | 23.57 | 23.82 | 14.17 | 14.46 | 13.17 | 13.21 | 12.37 | 10.7 | 12.06 | 13.16 | 13.83 | 14.33 | 14 | 15.2 |
EBITDA 1 | -8.278 | -4.504 | -4.624 | -3.666 | -1.884 | -1.284 | -0.499 | -1.293 | -4.251 | -4.881 | -0.9805 | -0.7278 | -0.4626 | -0.3 | -0.1 |
EBIT 1 | -11.72 | -11.55 | -11.64 | -5.526 | -10.71 | 2.973 | -1.752 | -2.259 | -5.165 | -5.63 | -2.262 | -2.134 | -1.944 | -1.7 | -1.5 |
Operating Margin | -58.53% | -49% | -48.89% | -39% | -74.05% | 22.57% | -13.27% | -18.26% | -48.28% | -46.67% | -17.19% | -15.43% | -13.56% | -12.14% | -9.87% |
Earnings before Tax (EBT) 1 | -12.16 | -10.99 | -20.16 | -4.328 | -9.76 | 0.028 | -3.866 | -2.011 | -2.699 | -6.131 | -2.755 | -2.627 | -2.437 | -2.2 | -2 |
Net income 1 | -12.49 | -9.452 | -18.98 | -127.8 | -33.03 | 0.309 | -3.459 | -2.15 | -3.289 | -5.623 | -2.69 | -2.568 | -2.38 | -2.2 | -2 |
Net margin | -62.35% | -40.1% | -79.67% | -901.82% | -228.39% | 2.35% | -26.19% | -17.38% | -30.74% | -46.61% | -20.44% | -18.57% | -16.61% | -15.71% | -13.16% |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 3/31/22 | 5/12/22 | 8/15/22 | 11/14/22 | 3/29/23 | 5/15/23 | 8/14/23 | 11/13/23 | 3/28/24 | 5/8/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow | - | - | -39 | -14.2 | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex | - | 2.62 | 4.58 | - | - | - | - |
Capex / Sales | - | 16.49% | 8.43% | - | - | - | - |
Announcement Date | 4/20/20 | 4/23/21 | 3/31/22 | 3/29/23 | 3/28/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+71.74% | 7.76M | |
+14.34% | 3.43B | |
+94.45% | 1.83B | |
+173.02% | 90.77M |
- Stock Market
- Equities
- IMCC Stock
- Financials IM Cannabis Corp.